02861oam 2200661I 450 991078644790332120230803024750.01-135-10431-X0-203-07359-21-283-86061-91-135-10432-810.4324/9780203073599(CKB)2670000000299183(EBL)1092619(OCoLC)820731283(SSID)ssj0000827131(PQKBManifestationID)12376477(PQKBTitleCode)TC0000827131(PQKBWorkID)10829162(PQKB)11689079(MiAaPQ)EBC1092619(Au-PeEL)EBL1092619(CaPaEBR)ebr10632380(CaONFJC)MIL417311(FINmELB)ELB133320(EXLCZ)99267000000029918320180706d2013 uy 0engur|n|---|||||txtccrTranslation in the digital age /Michael CroninMilton Park, Abingdon, Oxon ;New York :Routledge,2013.1 online resource (174 pages)New perspectives in translation studiesDescription based upon print version of record.0-415-60859-7 0-415-60860-0 Includes bibliographical references and index.Cover; Translation in the Digital Age; Title Page; Copyright Page; Table of Contents; Acknowledgements; Introduction: the translation age; 1 The house of translation; 2 Plain speaking; 3 Translating limits; 4 Everyware; 5 Details; Notes; Bibliography; Index<P>Translation is living through a period of revolutionary upheaval. The effects of digital technology and the internet on translation are continuous, widespread and profound. 　From automatic online translation services to the rise of crowdsourced translation and the proliferation of translation Apps for smartphones, the translation revolution is everywhere. The implications for human languages, cultures and society of this revolution are radical and far-reaching. In the Information Age that is the Translation Age, new ways of talking and thinking about translation which take full account of tNew Perspectives in Translation and Interpreting StudiesTranslating and interpretingTechnological innovationsMachine translatingInternetTranslating and interpretingTechnological innovations.Machine translating.Internet.418/.020285Cronin Michael1960-,477473MiAaPQMiAaPQMiAaPQBOOK9910786447903321Translation in the digital age1333110UNINA03515nam 2200625 450 991083037180332120230721005314.01-4443-0333-31-4443-0334-1(CKB)1000000000722805(EBL)416357(OCoLC)476247457(SSID)ssj0000104238(PQKBManifestationID)11140788(PQKBTitleCode)TC0000104238(PQKBWorkID)10079636(PQKB)11394892(MiAaPQ)EBC416357(EXLCZ)99100000000072280520160805h20092009 uy 0engur|n|---|||||txtccrAntiplatelet therapy in ischemic heart disease /Stephen D. WiviottHoboken, New Jersey :Wiley-Blackwell,2009.©20091 online resource (311 p.)American Heart Association Clinical SeriesIncludes index.1-4051-7626-1 Contents; Contributors; Preface; Foreword; PART I: Concepts in Platelet Physiology, Function, and Measurement; 1 Platelet physiology and the role of the platelet in ischemic heart disease; 2 Laboratory assessment of platelet function and the effects of antiplatelet agents; PART II: Pharmacology of Oral Antiplatelet Agents; 3 Cyclooxygenase inhibitors; 4 Aspirin response variability and resistance; 5 P2Y[sub(12)] inhibitors: Thienopyridines and direct oral inhibitors; 6 Thienopyridine response variability and resistance; PART III: Pharmacology of Intravenous Antiplatelet Agents7 Pharmacology of intravenous glycoprotein IIb/IIIa antagonists8 Intravenous P2Y[sub(12)] inhibitors; 9 Antiplatelet effects of thrombin inhibitors and fibrinolytic agents; PART IV: Clinical Use of Antiplatelet Agents in Cardiovascular Disease; 10 Antiplatelet therapy in acute coronary syndrome without ST elevation; 11 Antiplatelet therapy in ST-elevation myocardial infarction; 12 Antiplatelet therapy in chronic coronary artery disease; 13 Antiplatelet therapy in peripheral arterial disease; 14 Clinical use of antiplatelet agents in cardiovascular disease: cerebrovascular diseasesPART V: Special Circumstances15 Antiplatelet therapy and coronary bypass surgery: risks and benefits; 16 Management of antiplatelet therapy for non-cardiac surgery; 17 Antiplatelet therapy and coronary stents; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; Author Disclosure Table* Draws from expertise of leaders in antiplatelet therapy* Easy-to-use layout enables rapid browsing* Edited by a member of the prestigious TIMI study group with long-standing experience in the fieldAmerican Heart Association monograph.Coronary heart diseaseChemotherapyBlood plateletsAggregationCoronary heart diseasedrug therapyCoronary heart diseaseChemotherapy.Blood plateletsAggregation.Coronary heart diseasedrug therapy.616.12306616.123061Wiviott Stephen D.1342498Wiviott Stephen D1342498American Heart Association.MiAaPQMiAaPQMiAaPQBOOK9910830371803321Antiplatelet therapy in ischemic heart disease4047776UNINA